Literature DB >> 21605094

Predicting melanoma risk for the Australian population.

Victoria Mar1, Rory Wolfe, John W Kelly.   

Abstract

BACKGROUND: As melanoma incidence in Australia continues to rise, targeting high-risk individuals for early detection is of paramount importance.
OBJECTIVES: We aimed to design a population-specific risk assessment tool to improve on the use of intuition alone for assignment of surveillance strategies for high-risk individuals and help communicate risk more accurately and effectively to patients.
METHODS: Methods used in the development of breast cancer risk models were adopted. Data from a large meta-analysis was used to determine risk estimates. Attributable risk was calculated for each risk factor using data from the Victorian Melanoma Service. Local prevalence data from state cancer registries was incorporated to estimate 5-year risk of melanoma.
RESULTS: Independent risk factors identified were common naevi, atypical naevi, hair colour, freckles, family history of melanoma and personal history of non-melanoma skin cancer. Personal history of melanoma was the strongest risk factor for developing another (relative risk 7.28, 7.24). Absolute risk for individuals varies greatly with age, risk factor profiles and proximity to the equator.
CONCLUSION: We have developed a melanoma risk assessment tool based on the best available information (http://www.victorianmelanomaservice.org/calculator). The tool is easily modified as new information becomes available.
© 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21605094     DOI: 10.1111/j.1440-0960.2010.00727.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  15 in total

1.  Melanoma: A new strategy to reduce morbidity and mortality.

Authors:  Cameron Williams; Christopher Quirk; Anna Quirk
Journal:  Australas Med J       Date:  2014-07-31

Review 2.  Predicting melanoma risk: theory, practice and future challenges.

Authors:  David Whiteman
Journal:  Melanoma Manag       Date:  2014-12-04

3.  Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Authors:  Fangyi Gu; Ting-Huei Chen; Ruth M Pfeiffer; Maria Concetta Fargnoli; Donato Calista; Paola Ghiorzo; Ketty Peris; Susana Puig; Chiara Menin; Arcangela De Nicolo; Monica Rodolfo; Cristina Pellegrini; Lorenza Pastorino; Evangelos Evangelou; Tongwu Zhang; Xing Hua; Curt T DellaValle; D Timothy Bishop; Stuart MacGregor; Mark I Iles; Matthew H Law; Anne Cust; Kevin M Brown; Alexander J Stratigos; Eduardo Nagore; Stephen Chanock; Jianxin Shi; Melanoma Meta-Analysis Consortium; MelaNostrum Consortium; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

Review 4.  Survival is not the only valuable end point in melanoma screening.

Authors:  Clara Curiel-Lewandrowski; Caroline C Kim; Susan M Swetter; Suephy C Chen; Allan C Halpern; John M Kirkwood; Sancy A Leachman; Ashfaq A Marghoob; Michael E Ming; James M Grichnik
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

5.  Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.

Authors:  Lisa H Williams; Andrew R Shors; William E Barlow; Cam Solomon; Emily White
Journal:  J Clin Exp Dermatol Res       Date:  2011

6.  Independent validation of six melanoma risk prediction models.

Authors:  Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  J Invest Dermatol       Date:  2014-12-30       Impact factor: 8.551

7.  Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Authors:  Isabelle Kaiser; Sonja Mathes; Annette B Pfahlberg; Wolfgang Uter; Carola Berking; Markus V Heppt; Theresa Steeb; Katharina Diehl; Olaf Gefeller
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

Review 8.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

9.  Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.

Authors:  Mary Jane Sneyd; Claire Cameron; Brian Cox
Journal:  BMC Cancer       Date:  2014-05-22       Impact factor: 4.430

10.  Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.

Authors:  Lauren A Penn; Meng Qian; Enhan Zhang; Elise Ng; Yongzhao Shao; Marianne Berwick; DeAnn Lazovich; David Polsky
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.